Are effects on breastfed infants expected from patiromer sorbitex calcium taken during breastfeeding?

No effects on breastfed infants are expected from patiromer sorbitex calcium because maternal systemic exposure is negligible, but whether to discontinue breastfeeding or discontinue or abstain from therapy must be decided by weighing breastfeeding benefits for the child against treatment benefits for the woman.